Our translational research program is dedicated to the study of psychosis, a complex and often chronic psychiatric syndrome that is associated with a significant disease burden. We leverage multimodal neuroimaging techniques, pharmacological modeling, and computationally advanced data analytics to better characterize disease processes as a foundation for to the development of rational treatment approaches that are targeted at alleviating disease severity across symptom dimensions and improving overall outcomes for our patients.
